Figure 1: COVID-19 cases in Alberta by day and case status. Probable cases include cases where the lab confirmation is pending. Cases are under investigation and numbers may fluctuate as cases are resolved. Data included up to end of day April 04, 2022.
Characteristics
Table 1. COVID-19 cases in Alberta by age group and gender
Gender
Female
Male
Unknown
All
Age
Count
Percent
Count
Percent
Count
Percent
Count
Percent
Under 1 year
1,751
0
2,104
0
4
0
3,859
1
1-4 years
9,586
2
10,417
2
7
0
20,010
4
5-9 years
14,580
3
16,288
3
6
0
30,874
6
10-19 years
33,488
6
33,810
6
47
0
67,345
12
20-29 years
51,007
9
44,996
8
98
0
96,101
18
30-39 years
57,251
10
50,158
9
46
0
107,455
20
40-49 years
46,846
9
41,617
8
32
0
88,495
16
50-59 years
31,435
6
30,047
6
22
0
61,504
11
60-69 years
17,532
3
18,256
3
20
0
35,808
7
70-79 years
8,232
2
8,318
2
5
0
16,555
3
80+ years
10,888
2
6,974
1
5
0
17,867
3
Unknown
196
0
168
0
10
0
374
0
All
282,792
52
263,153
48
302
0
546,247
100
Figure 2: COVID-19 cases in Alberta by age group. First and second panels display counts (7-day rolling average) and rate per 100,000 (7-day rolling average), respectively.
Vaccinations
Vaccine Outcomes
Table 2. COVID-19 case outcomes in Alberta by vaccine status. Counts are provided for those currently identified as being hospitalized.
Outcome
Vaccine status
Count (n)
Percent (%)
Currently hospitalized
Three doses
405
40.91
Currently hospitalized
Two doses
277
27.98
Currently hospitalized
One dose
38
3.84
Currently hospitalized
Unvaccinated
270
27.27
Note:
* Vaccine status category is based on protection. Doses administered within 14 days prior to a person’s COVID-19 diagnosis are not considered protective; as a result, vaccination categories only include those identified as cases over 14 days past their first or second immunization date. * Table does not include those with 1 dose. As a result, percentages across rows or columns may not add to 100.
Total hospitalizations
Table 3. COVID-19 hospitalization, count and rate (per 100,000 population) in the past 120 days in Alberta by vaccine status Vaccine status category is based on protection as Table 2.
Age group
3 doses & hospitalized (n)
3 doses & hospitalized (rate per 100K)
2 doses & hospitalized (n)
2 doses & hospitalized (rate per 100K)
Unvaccinated & hospitalized (n)
Unvaccinated & hospitalized (rate per 100K)
Under 5 years
0
0.00
0
0.00
400
149.37
5-11 years
0
0.00
3
2.60
97
46.02
12-29 years
36
18.02
433
68.81
250
183.80
30-39 years
88
38.56
506
140.36
275
269.95
40-49 years
81
32.36
317
114.83
244
367.74
50-59 years
162
55.96
382
195.33
309
587.76
60-69 years
287
88.82
577
486.79
444
2180.37
70-79 years
530
260.77
560
1265.77
472
6378.38
80+ years
1045
977.82
547
2513.21
420
4931.05
5+ years
2229
139.22
3325
188.76
2911
482.05
Table 4. Hospitalized COVID-19 cases in the past 120 days in Alberta by vaccine status and pre-existing condition
Three doses
Two doses
Unvaccinated
with condition
no condition
with condition
no condition
with condition
no condition
Age group
Total (includes dose 1)
n
%
n
%
n
%
n
%
n
%
n
%
Under 5 years
400
0
–
0
–
0
–
0
–
60
15.0%
340
85.0%
5-11 years
132
0
–
0
–
2
1.5%
1
0.8%
40
30.3%
57
43.2%
12-29 years
787
17
2.2%
19
2.4%
146
18.6%
287
36.5%
83
10.5%
167
21.2%
30-39 years
929
39
4.2%
49
5.3%
169
18.2%
337
36.3%
101
10.9%
174
18.7%
40-49 years
690
61
8.8%
20
2.9%
183
26.5%
134
19.4%
128
18.6%
116
16.8%
50-59 years
894
134
15.0%
28
3.1%
296
33.1%
86
9.6%
203
22.7%
106
11.9%
60-69 years
1,358
259
19.1%
28
2.1%
491
36.2%
86
6.3%
342
25.2%
102
7.5%
70-79 years
1,607
505
31.4%
25
1.6%
516
32.1%
44
2.7%
391
24.3%
81
5.0%
80+ years
2,058
999
48.5%
46
2.2%
526
25.6%
21
1.0%
372
18.1%
48
2.3%
Unknown
1
0
–
0
–
0
–
0
–
0
–
1
100.0%
Note:
* Vaccine status category is based on protection as Table 2. * Pre-existing conditions include respiratory diseases, diabetes, stroke, dementia, cardiovascular disease, liver diseases, renal diseases, cancer and immuno-deficiency diseases. * Table does not include those with 1 dose. As a result, percentages across rows or columns may not add to 100.
ICU hospitalizations
Table 5. COVID-19 ICU admission, count and rate (per 100,000 population), in the past 120 days in Alberta by vaccine status. Vaccine status category is based on protection as Table 2.
Age group
3 doses & admitted in ICU (n)
3 doses & admitted in ICU (rate per 100K)
2 doses & admitted in ICU (n)
2 doses & admitted in ICU (rate per 100K)
Unvaccinated & admitted in ICU (n)
Unvaccinated & admitted in ICU (rate per 100K)
Under 5 years
0
0.00
0
0.00
58
21.66
5-11 years
0
0.00
0
0.00
14
6.64
12-29 years
1
0.50
17
2.70
28
20.59
30-39 years
1
0.44
17
4.72
26
25.52
40-49 years
7
2.80
27
9.78
58
87.41
50-59 years
24
8.29
58
29.66
80
152.17
60-69 years
37
11.45
77
64.96
93
456.70
70-79 years
48
23.62
46
103.97
73
986.49
80+ years
19
17.78
12
55.13
10
117.41
5+ years
137
8.56
254
14.42
440
72.86
Table 6. Hospitalized COVID-19 cases in ICU in the past 120 days in Alberta by vaccine status
Three doses
Two doses
Unvaccinated
Age group
Total (includes dose 1)
n
%
n
%
n
%
Under 5 years
58
0
–
0
–
58
100.0%
5-11 years
16
0
–
0
–
14
87.5%
12-29 years
53
1
1.9%
17
32.1%
28
52.8%
30-39 years
47
1
2.1%
17
36.2%
26
55.3%
40-49 years
99
7
7.1%
27
27.3%
58
58.6%
50-59 years
168
24
14.3%
58
34.5%
80
47.6%
60-69 years
215
37
17.2%
77
35.8%
93
43.3%
70-79 years
172
48
27.9%
46
26.7%
73
42.4%
80+ years
42
19
45.2%
12
28.6%
10
23.8%
Note:
* Vaccine status category is based on protection as Table 2. * Pre-existing conditions include respiratory diseases, diabetes, stroke, dementia, cardiovascular disease, liver diseases, renal diseases, cancer and immuno-deficiency diseases. * Table does not include those with 1 dose. As a result, percentages across rows or columns may not add to 100.
Table 7. Hospitalized COVID-19 cases in ICU in the past 120 days in Alberta by vaccine status and pre-existing condition
Three doses
Two doses
Unvaccinated
with condition
no condition
with condition
no condition
with condition
no condition
Age group
Total (includes dose 1)
n
%
n
%
n
%
n
%
n
%
n
%
All ages
870
128
14.7%
9
1.0%
204
23.4%
50
5.7%
274
31.5%
166
19.1%
Note:
* Vaccine status category is based on protection as Table 2. * Pre-existing conditions include respiratory diseases, diabetes, stroke, dementia, cardiovascular disease, liver diseases, renal diseases, cancer and immuno-deficiency diseases. * Table does not include those with 1 dose. As a result, percentages across rows or columns may not add to 100.
Deaths
Table 8. COVID-19 deaths, count and rate (per 100,000 population), in the past 120 days in Alberta by vaccine status. Vaccine status category is based on protection as Table 2.
Age group
3 doses & died (n)
3 doses & died (rate per 100K)
2 doses & died (n)
2 doses & died (rate per 100K)
Unvaccinated & died (n)
Unvaccinated & died (rate per 100K)
Under 5 years
0
0.00
0
0.00
0
0.00
5-11 years
0
0.00
0
0.00
2
0.95
12-29 years
0
0.00
3
0.48
2
1.47
30-39 years
0
0.00
6
1.66
5
4.91
40-49 years
2
0.80
4
1.45
11
16.58
50-59 years
7
2.42
13
6.65
27
51.36
60-69 years
26
8.05
51
43.03
36
176.79
70-79 years
65
31.98
67
151.44
71
959.46
80+ years
211
197.44
100
459.45
98
1150.58
5+ years
311
19.42
244
13.85
252
41.73
Table 9. COVID-19 deaths in the past 120 days in Alberta by vaccine status
Three doses
Two doses
Unvaccinated
Age group
Total (includes dose 1)
n
%
n
%
n
%
5-11 years
2
0
–
0
–
2
100.0%
12-29 years
5
0
–
3
60.0%
2
40.0%
30-39 years
11
0
–
6
54.5%
5
45.5%
40-49 years
20
2
10.0%
4
20.0%
11
55.0%
50-59 years
49
7
14.3%
13
26.5%
27
55.1%
60-69 years
117
26
22.2%
51
43.6%
36
30.8%
70-79 years
212
65
30.7%
67
31.6%
71
33.5%
80+ years
419
211
50.4%
100
23.9%
98
23.4%
Note:
* Vaccine status category is based on protection as Table 2. * Pre-existing conditions include respiratory diseases, diabetes, stroke, dementia, cardiovascular disease, liver diseases, renal diseases, cancer and immuno-deficiency diseases. * Table does not include those with 1 dose. As a result, percentages across rows or columns may not add to 100.
Table 10. COVID-19 deaths in the past 120 days in Alberta by vaccine status and pre-existing condition
Three doses
Two doses
Unvaccinated
with condition
no condition
with condition
no condition
with condition
no condition
Age group
Total (includes dose 1)
n
%
n
%
n
%
n
%
n
%
n
%
All ages
835
301
36.0%
10
1.2%
224
26.8%
20
2.4%
216
25.9%
36
4.3%
Note:
* Vaccine status category is based on protection as Table 2. * Pre-existing conditions include respiratory diseases, diabetes, stroke, dementia, cardiovascular disease, liver diseases, renal diseases, cancer and immuno-deficiency diseases. * Table does not include those with 1 dose. As a result, percentages across rows or columns may not add to 100.
Figure 3: Current non-ICU (top) and ICU(bottom) hospitalizations by vaccine status. Note: Time from immunization date to COVID-19 diagnosis date (or Date reported to Alberta Health). COVID-19 hospitalizations reported are not due to immunization events.
Severe Outcomes
Table 11. Total Hospitalizations, ICU admissions and deaths (ever) among COVID-19 cases in Alberta by age group
Age Group
Cases
Hospitalized
ICU
Deaths
Count
Count
Case rate
Pop. rate
Count
Case rate
Pop. rate
Count
Case rate
Pop. rate
Total
546247
23031
4.2
521.1
3738
0.7
84.6
4104
0.8
92.8
Under 1 year
3859
298
7.7
590.3
61
1.6
120.8
0
0.0
0.0
1-4 years
20010
268
1.3
123.3
28
0.1
12.9
1
0.0
0.5
5-9 years
30874
143
0.5
51.5
23
0.1
8.3
2
0.0
0.7
10-19 years
67345
443
0.7
83.1
52
0.1
9.8
2
0.0
0.4
20-29 years
96101
1334
1.4
225.6
153
0.2
25.9
20
0.0
3.4
30-39 years
107455
2240
2.1
313.1
293
0.3
41.0
45
0.0
6.3
40-49 years
88495
2440
2.8
401.1
494
0.6
81.2
100
0.1
16.4
50-59 years
61504
3341
5.4
606.4
820
1.3
148.8
256
0.4
46.5
60-69 years
35808
3980
11.1
839.1
965
2.7
203.4
569
1.6
120.0
70-79 years
16555
3972
24.0
1523.4
665
4.0
255.0
964
5.8
369.7
80+ years
17867
4564
25.5
3244.8
183
1.0
130.1
2144
12.0
1524.3
Unknown
374
8
2.1
NA
1
0.3
NA
1
0.3
NA
Note:
Based on total hospitalizations and ICU admissions ever.
Row percent is out of the number of cases in each age group.
Each ICU admission is also included in the total number of hospitalization
Case rate (per 100 cases)
Population rate (per 100,000 population)
Figure 4: Number of current COVID-19 patients in hospital, ICU and non-ICU
Table 12. Reasons for new COVID-19 ICU and non-ICU hospital admissions since January 10, 2022 (all admissions) and the last 7 days
All Admissions
Last 7 days
Non-ICU
ICU
Non-ICU
ICU
Reason Type
n
%
n
%
n
%
n
%
Primary COVID admission
2183
37.9
246
47.7
122
42.1
6
50.0
COVID-contributing admission
1487
25.8
158
30.6
89
30.7
3
25.0
Incidental
1992
34.6
111
21.5
70
24.1
3
25.0
Unable to determine
93
1.6
1
0.2
9
3.1
0
0.0
Total
5755
100.0
516
100.0
290
100.0
12
100.0
Note:
* Only hospitalizations with available reason types are included. * Incidental hospitalizations are those where a COVID-positive person has been hospitalized but their reason for admission was deemed to be unrelated to their COVID diagnosis. * For recent hospital admissions, there may be a delay in reason type information. This may lead to some fluctuations in day-to-day information for “All Admissions” compared to those reported in the “Last 7 days”.
Figure 5: Rate of new hospitalizations (7-day rolling average, average of current day and previous 6 days) by admission date in Alberta and by zone
Figure 6: Daily COVID-19 attributed deaths. Data are subject to change; when death date is unavailable the date reported to Alberta Health is used until a death date is known.
Healthcare Capacity
Figure 7: Intensive Care Unit (ICU) bed capacity. Data included may only be available and updated at a lagged interval. As a result, the number of COVID occupied ICU beds on a particular day may not match the number reported elsewhere on the dashboard.
Figure 8: Total ICU bed capacity over time. Data included may only be available and updated at a lagged interval. As a result, the number of COVID occupied ICU beds on a particular day may not match the number reported elsewhere on the dashboard.
Figure 9: Non-ICU bed capacity. Data included may only be available and udpated at a lagged interval. As a result, the number of COVID occupied inpatient beds on a particular day may not match the number reported elsewhere on the dashboard. Data reflects the non-ICU hospital occupancy at the 14 largest hospitals, excluding pediatrics.
Geospatial
Figure 10: Cumulative COVID-19 cases in Alberta by zone and date reported to Alberta Health. Cases without a postal code or incorrect postal codes are labelled as unknown.
Geographies can be displayed by municipality or local geographic area (LGA). When viewing by municipality, regions are defined by metropolitan areas, cities, urban service areas, rural areas, and towns with approximately 10,000 or more people; smaller regions (i.e. villages, and reserves) are incorporated into the corresponding rural area. Cases without a postal code or incorrect postal codes are not included.
Laboratory Testing
Figure 11: Tests performed for COVID-19 in Alberta by day. Tests can be performed for the same person multiple times.
Figure 12: Cumulative and daily test positivity rate for COVID-19 in Alberta.
Figure 13: Positivity rate for COVID-19 in Alberta by zone.
Variants of Concern
Summary
NOTE: People are identified as COVID-19 cases prior to variant of concern identification. As such, variant of concern reporting is delayed compared to date the case was reported to Alberta Health.
Due to the large number of positive COVID-19 cases, the lab screened a sample of positive cases between May 1, 2021 and May 31, 2021, September 9, 2021 and November 23, 2021, and December 23rd, 2021 and February 9, 2022.
202,696 variants of concern identified
1,829 died
Figure 14: Variant of concern COVID-19 cases in Alberta by day. Note: cases are identified as COVID-19 positive prior to being identified as a variant of concern. Data included up to end of day April 04, 2022.
Note: Genotype classification is based on the most specific typing available at time of reporting, either sequencing or screening results.
Table 13. Variants of concern COVID-19 cases identified in Alberta and by Zone
Zone
Alpha
Beta
Delta
Gamma
Kappa
Omicron
Total
Calgary Zone
20,045
79
16,384
803
7
39,177
76,495
Central Zone
5,457
2
8,569
193
0
8,760
22,981
Edmonton Zone
11,433
65
22,940
1,064
13
24,839
60,354
North Zone
6,253
34
14,178
767
0
6,847
28,079
South Zone
2,684
0
6,138
97
0
5,856
14,775
Unknown
0
0
2
0
0
10
12
Alberta
45,872
180
68,211
2,924
20
85,489
202,696
Wastewater surveillance
Project Details
The Alberta Wastewater Surveillance Program is a collaboration between the University of Calgary, University of Alberta, Alberta Precision Labs, and Alberta Health. SARS-CoV-2 virus has been demonstrated to be passed in the feces of a significant proportion of infected individuals, individuals infected with COVID-19 may pass the virus in their feces before they become asymptomatic. As such wastewater can provide an early indication of infection trends in a community. Wastewater monitoring is one of many tools in understanding the overall burden of infection in a community, and provides a broad picture of infection in a community.
More details on this project and additional wastewater data can be viewed on the University of Calgary’s Center for Health Informations’ COVID-19 wastewater dashboard
Click on your community’s Zone below to view its’ wastewater data
Figure 15: Average quantity of SARS CoV-2 virus (viral copies/mL) over time.
Wastewater Data is updated with the most current data delivered to Alberta Health. This data is received around the same time data is updated on the University of Calgary’s CHI Health tracker Monday, Wednesday, and Friday afternoons. These data are incorporated into Alberta Health wastewater reporting on the next scheduled reporting date. As such, there may be short and temporary discrepancies between the wastewater data displayed between the two websites. For more information on wastewater data interpretation, see the Data Notes tab.
Data Export
Data are subject to change. Fluctuations are expected as cases are investigated and updated. Data are provided for export in csv format.
The Provincial Surveillance Information system (PSI) is a laboratory surveillance system which receives positive results for all Notifiable Diseases and diseases under laboratory surveillance from Alberta Precision Labs (APL). The system also receives negative results for a subset of organisms such as COVID-19. The system contains basic information on characteristics and demographics such as age, zone and gender. The Communicable Disease Reporting System (CDRS) at Alberta Health and the Communicable Disease Outbreak Management (CDOM) system at Alberta Health Services contains information on COVID-19 cases. Data Integration and Measurement Reporting (DIMR) database at Alberta Health Services contains up to date information on people admitted and discharged from hospital in Alberta. Information such as hospitalizations and ICU admissions are received through enhanced case report forms sent by Alberta Health Services (AHS).
COVID-19 vaccinations and AEFIs are reported to the Provincial Immunization and Adverse Reaction to Immunization (Imm/ARI) repository. In Alberta, all health practitioners are required by law to report Adverse Events Following Immunization (AEFI) to Imm/ARI. The reporting requirements are outlined in the Immunization Regulation, under the Public Health Act. Case definitions are further defined in the AEFI Policy. As of January 1, 2021, all health practitioners are required to report all (both provincially funded and privately purchased) vaccinations electronically to Imm/ARI.
Wastewater surveillance data
Due to differences in Wastewater composition across the province, data should not be compared between municipalities. Instead, good practice when analyzing wastewater data is to look at the general trend within a community. Two SARS CoV-2 gene targets, the N1 and N2 genes, are tested for in the wastewater. The average signal in gene copies/mL is presented.
Definitions
COVID-19 Deaths
A death resulting from a clinically compatible illness, in a probable or confirmed COVID-19 case, unless there is a clear alternative cause of death identified (e.g., trauma, poisoning, drug overdose).
A Medical Officer of Health or relevant public health authority may use their discretion when determining if a death was due to COVID-19, and their judgement will supersede the above criteria.
A death due to COVID-19 may be attributed when COVID-19 is the cause of death or is a contributing factor.
Lab Positivity
COVID-19 percent positivity in Alberta is calculated using the Test Over Test method, which is the same method employed by the US Centers for Disease Control and Prevention. The calculation is as follows:
Daily Number of Positive Tests / (Daily Number of Positive Tests + Daily Number of Negative Tests)
Q/RT-PCR tests are the only COVID-19 tests included in this calculation.
The following pre-existing conditions are included in respective analyses: diabetes, hypertension, COPD, cancer, dementia, stroke, liver cirrhosis, cardiovascular diseases (including IHD and congestive heart failure), chronic kidney disease, and immuno-deficiency diseases.
Vaccine coverage
Individuals who received at least one dose was calculated as (# of individuals who received at least one dose) / (population estimate). Those who received two doses was calculated as (# of individuals who received two doses) / (population estimate).
As of January 19, 2022 all doses administered in First Nations communities are submitted directly into Imm/ARI and the data reconciliation resulted in the removal of approximately 20,000 doses.
Disclaimer
The content and format of this report are subject to change. Cases are under investigation and numbers may fluctuate as cases are resolved. Data included in the interactive data application are up-to-date as of end of day April 04, 2022.
8,603,560 total doses administered
90.2% 12+ population with 1 dose
86.7% 12+ population with 2 doses
Vaccination data are up-to-date as of end of day April 04, 2022
8,603,560 doses of COVID-19 vaccine have been administered in Alberta
90.2 percent of 12+ population with 1 dose (81.1% total population)
86.7 percent of 12+ population with 2 doses (76.6% total population)
Number of COVID-19 vaccine doses administered by dose and day**
Table 1. Breakdown of COVID-19 vaccine doses administered by provider.
Dose 1
Dose 2
Dose 3
Dose 4
Total administered
Alberta Health Services
1,879,727
1,628,589
392,663
3,729
3,904,708
Pharmacies
1,584,823
1,645,138
1,188,327
17,291
4,435,579
Other
118,590
105,349
39,005
329
263,273
Total
3,583,140
3,379,076
1,619,995
21,349
8,603,560
Note: Other includes submissions from First Nations communities and online submissions from other providers (e.g. physician clinics).
Cumulative percent of individuals who received one dose, two doses and three doses by day in Alberta
Table 2. Summary of COVID-19 vaccine doses administered and vaccine coverage by age group
Age group
Population
1 dose
% of population with 1 dose
2 doses
% of population with 2 doses
3 doses
% of population with 3 doses
4 doses
Total administered
05-11
391,430
189,574
48.4
123,858
31.6
62
0.0
1
313,495
12-14
162,518
142,105
87.4
136,145
83.8
10,183
6.3
18
288,451
15-19
256,700
223,648
87.1
213,178
83.0
40,244
15.7
72
476,953
20-24
276,916
239,625
86.5
225,186
81.3
66,688
24.1
116
531,113
25-29
314,340
261,750
83.3
247,039
78.6
79,150
25.2
169
587,434
30-34
356,224
300,493
84.4
286,486
80.4
103,971
29.2
287
690,263
35-39
359,135
313,317
87.2
301,755
84.0
122,196
34.0
411
736,637
40-44
319,735
284,536
89.0
277,061
86.7
126,503
39.6
1,402
688,560
45-49
288,613
257,678
89.3
250,855
86.9
125,738
43.6
1,716
635,186
50-54
266,607
243,000
91.1
236,807
88.8
133,658
50.1
1,794
614,596
55-59
284,313
255,526
89.9
247,323
87.0
153,347
53.9
2,894
658,550
60-64
264,324
249,460
94.4
242,758
91.8
170,103
64.4
7,339
669,273
65-69
209,995
204,620
97.4
201,043
95.7
157,905
75.2
1,650
564,979
70-74
157,696
154,667
98.1
154,309
97.9
126,113
80.0
1,342
436,296
75-79
103,045
98,730
95.8
97,685
94.8
87,952
85.4
1,167
285,449
80-84
68,661
64,856
94.5
64,161
93.4
56,872
82.8
632
186,508
85-89
44,188
41,233
93.3
40,725
92.2
35,963
81.4
250
118,158
90+
27,809
26,072
93.8
25,744
92.6
23,358
84.0
89
75,259
Unknown
0
32,250
0.0
14,146
0.0
5
0.0
0
46,400
18+
3,444,862
3,119,133
90.5
2,999,614
87.1
1,596,624
46.3
21,299
7,729,468
12+
3,760,818
3,393,566
90.2
3,262,406
86.7
1,619,949
43.1
21,348
8,290,065
5+
4,152,248
3,583,140
86.3
3,386,264
81.6
1,620,011
39.0
21,349
8,603,560
ALL
4,420,039
3,583,140
81.1
3,386,264
76.6
1,620,011
36.7
21,349
8,603,560
Note 1: individuals who received a first dose in one age category may cross into another age category for a second or third dose.
Note 2: The age group 5-11 year olds includes those who received the Pfizer-BioNTech Comirnaty pediatric COVID-19 vaccine and those who were eligible to receive the Pfizer-BioNTech Comirnaty COVID-19 vaccine because they were 11 but would turn 12 in 2021.
Vaccine coverage by day, dose and age group in Alberta
Vaccine coverage rate by local geographic area**
Geographies can be displayed by Alberta local geographic area (LGA). Individuals without a postal code or incorrect postal codes are not included. The colour categories for each LGA are based on the percent of the population (all ages) vaccinated. Vaccine uptake rates for the Vermilion River County LGA are underestimated as the Saskatchewan Health Authority provides public health services to all residents of Lloydminster.
2,660 adverse events following immunization (AEFI) have been reported to Alberta Health. This represents 2,562 people, and 2,782 symptoms.
1,705 related to Pfizer
696 related to Moderna
218 related to AstraZeneca
There have been 5,468 vaccine refusals and 8,661 contraindications to receiving the vaccine
Number of adverse events following immunization (AEFI) by condition reported in Alberta
Note: Information is collected on individuals and reported to Alberta Health when an AEFI is confirmed. One AEFI report can have multiple events associated with it.
Age group
AEFIs (n)
Percent of doses administered (%)
Rate (per 100,000 doses administered)
Total doses administered
00-04
0
0.000
0.0
0
05-11
38
0.012
12.1
313,495
12-14
56
0.019
19.4
288,451
15-19
115
0.024
24.1
476,953
20-24
149
0.028
28.1
531,113
25-29
176
0.030
30.0
587,434
30-34
273
0.040
39.6
690,263
35-39
254
0.034
34.5
736,637
40-44
320
0.046
46.5
688,560
45-49
249
0.039
39.2
635,186
50-54
217
0.035
35.3
614,596
55-59
234
0.036
35.5
658,550
60-64
207
0.031
30.9
669,273
65-69
131
0.023
23.2
564,979
70-74
108
0.025
24.8
436,296
75-79
57
0.020
20.0
285,449
80-84
27
0.014
14.5
186,508
85-89
27
0.023
22.9
118,158
90+
15
0.020
19.9
75,259
Unknown
7
0.000
0.0
0
All
2,660
0.031
30.9
8,603,560
Note: The age group 5-11 year olds includes those who received the Pfizer-BioNTech Comirnaty pediatric COVID-19 vaccine and those who were eligible to receive the Pfizer-BioNTech Comirnaty COVID-19 vaccine because they were 11 but would turn 12 in 2021.